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Abstract
A/J and 129P3/J mouse strains have different susceptibilities to dental fluorosis due to their genetic backgrounds. They also
differ with respect to several features of fluoride (F) metabolism and metabolic handling of water. This study was done to
determine whether differences in F metabolism could be explained by diversities in the profile of protein expression in
kidneys. Weanling, male A/J mice (susceptible to dental fluorosis, n = 18) and 129P3/J mice (resistant, n = 18) were housed in
pairs and assigned to three groups given low-F food and drinking water containing 0, 10 or 50 ppm [F] for 7 weeks. Renal
proteome profiles were examined using 2D-PAGE and LC-MS/MS. Quantitative intensity analysis detected between A/J and
129P3/J strains 122, 126 and 134 spots differentially expressed in the groups receiving 0, 10 and 50 ppmF, respectively.
From these, 25, 30 and 32, respectively, were successfully identified. Most of the proteins were related to metabolic and
cellular processes, followed by response to stimuli, development and regulation of cellular processes. In F-treated groups,
PDZK-1, a protein involved in the regulation of renal tubular reabsorption capacity was down-modulated in the kidney of
129P3/J mice. A/J and 129P3/J mice exhibited 11 and 3 exclusive proteins, respectively, regardless of F exposure. In
conclusion, proteomic analysis was able to identify proteins potentially involved in metabolic handling of F and water that
are differentially expressed or even not expressed in the strains evaluated. This can contribute to understanding the
molecular mechanisms underlying genetic susceptibility to dental fluorosis, by indicating key-proteins that should be better
addressed in future studies.
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Introduction
The widespread use of F has contributed to the caries decline,
but excessive intake may affect both bone metabolism and enamel
development, causing skeletal and dental fluorosis, respectively.
There are many sources of F intake, such as drinking water, dental
products, dietary supplements and infant formulas [1]. There is
evidence that the prevalence of dental fluorosis (DF) is increasing
worldwide both in fluoridated and non-fluoridated communities
[2]. In the US, 23% of 6- to 39-yr-old subjects present enamel
fluorosis, ranging from very low to relatively high in severity [3].
However, the exact mechanisms by which F affects biomineraliza-
tion are not completely understood [4,5]. It has been proposed
that genetic determinants influence the susceptibility to DF in
humans [6] and mice [7]. Two strains of mice have been identified
with distinct responses to the effects of F in the mineralized tissues.
The A/J strain is ‘‘susceptible’’, with a rapid onset and severe
development of DF, while the 129P3/J is ‘‘resistant’’, with
minimum development of DF [7]. These strains also differ
regarding their susceptibilities to the effects of F in bone [8,9].
To determine whether such differences were due to differences
in F metabolism, we conducted a metabolic study in which total F
intake and excretion were measured. Our results showed that,
compared to A/J mice, 129P3/J mice ingested less water, excreted
less urine, had lower urinary F excretion and consequently had
higher F retention and plasma and femur F levels [10]. However,
these findings were not able to explain the mechanisms underlying
the differences in the metabolic handling of F.
Kidneys represent the major route of removal of F from the
body [11]. After F enters the renal tubules, a variable amount is
reabsorbed, depending on the urinary pH because transmembrane
migration occurs by diffusion of HF [12]. Thus, any factor that
affects urinary pH will have an impact on the amount of F that is
excreted in urine [11]. Urinary F excretion is also influenced by
glomerular filtration rate since its reduction, as occurs in chronic
renal dysfunction as well as in the last decades of life, results in
lower excretion and increased plasma F levels [13]. Considering
that kidney is a key organ in the metabolism of F, we then sought
to investigate the molecular mechanisms underlying the renal F
metabolism in A/J and 129P3/J mice that may account for their
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differential metabolic handling of F. To address this, proteomic
analyses were performed on kidneys of A/J and 129P3/J mice
receiving both low and high level of F-containing water.
Materials and Methods
Animals and Treatment
Male mice from the A/J and 129P3/J inbred strains (3-week-
old) were randomly distributed into three groups (n = 6/strain)
based on the F concentrations in the drinking water. All animals
were housed in pairs in metabolic cages with ad libitum access to
low-F food (AIN76A, PMI Nutrition, Richmond, IN, USA,
0.95 mg/Kg F) and water, to allow analysis of water and food
consumption [10]. The temperature and humidity in the climate-
controlled room, which had a 12-h light/dark cycle, were 2361uC
and 40%–80%, respectively. All experimental protocols were
approved by the Ethics Committee for Animal Experiments of
Bauru Dental School, University of Sao Paulo (Protocol # 026/
2007). Experimental groups received drinking water containing 10
(low) or 50 (high) ppm F ion (as NaF), for 60 days. Control group
received deionized water for the same period. At the end of the
study, the mice were anesthetized with ketamine/xylazine and
kidneys were collected. The left kidney was washed with cold
buffer containing Tris 100 mM, EDTA 1 mM, PMSF 1 mM,
pH 7.4, frozen at liquid nitrogen and kept at -80uC until
proteomic analysis. The right kidney was collected for F analysis.
F analysis in kidney
Kidneys were homogenized in deionized water for 2 min using
a homogenizer (Marconi, Model MA 102). Kidney F concentra-
tions were determined in duplicate (100 mg of kidney tissue) after
overnight hexamethyldisiloxane (HMDS)-facilitated diffusion
[14,15] using the ion-specific electrode (Orion Research, Model
9409) and a miniature calomel electrode (Accumet, #13-620-79)
both coupled to a potentiometer (Orion Research, Model EA 940).
F standards (0.00475 to 0.19 mgF) were prepared in triplicate and
diffused in the same manner as the samples. In addition,
nondiffused standards were prepared to have exactly the same F
concentrations as the diffused standards. Comparison of the mV
readings demonstrated that the F in the diffused standards had
been completely trapped and analyzed (recovery.95%). The mV
potentials were converted to mg F using a standard curve with a
coefficient correlation of r$0.99.
Sample Preparation for 2DE
Kidney samples were homogenized using mortar and pestle in
liquid nitrogen. Denaturation buffer (7 M urea, 2 M de thioureia,
4% CHAPS, 1% DTT and 0.5% IPG pH 3–10, GE Healthcare,
Uppsala, Sweden) was added. After 1 h vortexing at 4uC, samples
were centrifuged at 250006g for 30 min at 4uC for supernatants
collection. The proteins were precipitated by using the kit PlusOne
2D Cleanup (GE Healthcare, Uppsala, Sweden), as recommended
by the manufacturer. The pellets were resuspended in rehydration
buffer (8 M urea, 0.5% CHAPS, 10% glycerol, 0.5% IPG buffer
pH 3–10, 7 mg/2.5 mL DTT, 0.002% bromophenol blue).
Protein concentration was measured in each sample by Bradford
protein assay. After quantification, 1000 mg of kidney proteins
from each animal of the same group and strain were combined to
constitute a pool [16] that was submitted to proteomic analysis in
triplicate, as described below.
2-DE Separation
Renal proteins (1000 mg) were taken from each pooled sample
and mixed in rehydration buffer to a volume of 400 mL which was
then loaded onto 24-cm IPG strips (linear pH 3–10). Rehydration
and first-dimensional IEF were performed on IPGphor IEF system
at 20uC with the following parameters: 50V for 12 h, 500V for
1 h, 1000V gradient for 1 h, then 10000 V for a total 40,000 V.
Ettan DALTsix (GE Healthcare) (GE Healthcare, Uppsala, Sweden)
with homemade12.5% acrylamide gels was used for the second
dimension separation. Electrophoresis was performed at 15 mA/
gel (80V) for 1 h and at 60 mA/gel (500V) until bromophenol blue
line had reached the bottom of the gels. The resolved protein spots
were stained with Colloidal Coomassie Brilliant Blue G-250 [17].
Gels were scanned with an Imagemaster scanner, and all images
were analyzed by ImageMASTER 2D Platinum 7.0 software (GE
Healthcare, Uppsala, Sweden). Parameters used for spot detection
were minimal area= 5 pixels; smooth factor = 4; and salien-
cy = 100. The gel chosen as the reference had the highest number
of spots. The reference gel was then used for matching of
corresponding protein spots between gels. Following average mode
of background subtraction, individual spot intensity volume was
normalized with total intensity volume (summation of the intensity
volumes obtained from all spots in the same 2-DE gel). The
normalized intensity volume values of individual protein spots
were then used to determine differential protein expression
between control and experimental groups. 2D spots that exhibited
a twofold or more decrease or increase were tested for statistical
significance. Analysis of 2D-gel variability among the replicates of
each experimental condition was taken by using the relative
volume (% vol). The correlation coefficients among the triplicates
are shown to vary from 0.9385 to 0.9821 (Figure S4 -
Supplementary information).
LC-MS/MS Analysis
Protein spots of interest were excised from the gel and destained
three times with 25 mM Ambic/Acetonitrile (50:50 v/v) for
30 min. The destained gel pieces were dehydrated twice with
acetonitrile (ACN) for 10 min and dried in a vacuum concentrator
(Eppendorf, Hamburg, Germany). The dried gel pieces were
rehydrated with 20 mM DTT in 50 mM Ambic for 40 min at
56uC. Excess of reagent was removed and 55 mM iodoacetamide
(IAA) in Ambic 50 mM was added for 30 min RT at dark. The
remaining liquid was removed and washed out with 25 mM
Ambic, followed by dehydration with ACN. After its removal, the
gels were dried again. For digestion, dried gels were incubated
with 10 ng/mL trypsin in 25 mM Ambic for 15 min (Trypsin Gold
Mass spectrometry, Promega, Madison, USA). Peptides were
sequentially extracted from the gels initially in 50% ACN (v/v)
with 5% formic acid for 14 h at 37uC, then in 50% ACN (v/v)
with 1% formic acid for 15 min, followed by 60% methanol (v/v)
with 1% formic acid for 15 min and twice with 100% ACN at
45uC under sonication (40kHz/30W, Branson, Danbury, USA).
Extracts were dried using a vacuum concentrator (Eppendorf,
Hamburg, Germany) and kept at -20uC. Prior to MS identifica-
tion, dried peptides were dissolved in 12 mL 0.1% formic acid. The
peptides were identified and quantified by LC-ESI-Q-TOF MS
(Liquid Chromatography Electrospray Ionization Quadrupole
Time of Flight Mass Spectrometry) (Waters, Mildord, USA).
MassLynx 4.1 SCN662 software (Waters, Mildord, USA) was used
to submit the combined MS and MS/MS data to MASCOT
database search engine (http://www.matrixscience.com) (version
2007.12.04) based on IPI (International Protein Index) protein
database restricted to taxonomies Mus musculus (Mouse). The
search was limited with a mass tolerance of 100 ppm and only one
missed cleavage per peptide was allowed. For modification of
peptides, cysteine carbamido-methylation (fixed) and methionine
oxidation (variable) were considered. Significant matching protein
Proteomic of F Renal Metabolism in Mice
PLOS ONE | www.plosone.org 2 January 2013 | Volume 8 | Issue 1 | e53261
required score of .60. Accuracy between the theoretical and
experimental obtained mass and pI were also considered. When
2 or more proteins with high scores were identified in the same
spot, they are excluded from analysis. Identified proteins were
classified into 6 different categories according to their primary
function [18].
Statistical Analysis
For kidney F concentration, the software GraphPad InStat
version 4.0 for Windows (GraphPad software Inc., La Jolla, USA)
was used. Data were analysed by 2-way ANOVA and Bonferroni
test for individual comparisons (p,0.05).
For proteomic data, statistical analysis was performed using
ANOVA available at ImageMaster 2D Platinum 7.0 software (GE
Healthcare, Uppsala, Sweden). Only proteins with significantly
altered levels were excised for identification by LC-MS/MS
(p,0.05).
Results
Renal F Concentration
Mean kidney F (6se) concentrations for A/J mice for control,
10 ppmF and 50 ppmF groups were: 0.12660.008, 0.17460.007
and 0.29660.026 mg/g. The corresponding values for 129P3/J
mice were 0.13960.015, 0.16360.010 and 0.19860.046 mg/g,
respectively. Two-way ANOVA revealed a significant difference
among the treatments (F= 35.13, p,0.0001), but not between the
strains (F= 0.099, p = 0.756) without significant interaction
between these criteria (F= 0.124, p = 0.884). For both strains,
significantly higher kidney F concentrations were found for the
50 ppmF group, when compared with control and 10 ppmF
groups that did not significantly differ from each other.
Identification of Differentially Expressed Proteins
For the statistical analysis, comparisons were performed
between the strains as follows: Control groups (A/J vs 129P3/J
mice), 10 ppmF groups (A/J vs 129P3/J mice), and 50 ppmF
groups (A/J vs 129P3/J mice). Tables 1–3 show the proteins that
were differentially expressed (p,0.05) in each comparison.
Representative 2D map of each comparison is also shown in the
Supplementary Information (Figures S1-S3). Quantitative intensi-
ty analysis showed 26 changed spots between control groups
(Table 1). Among them, 14 spots were up-modulated, while were
12 down-regulated in control 129P3/J mice, when compared to
control A/J mice. In general, the kidney proteome dataset was
found to be significantly related with several metabolic and cellular
processes pathways. Most of the 14 proteins up-modulated in the
kidney of 129P3/J mice are related with metabolism (57.2%),
while 28.6% are involved in cell processes and the remainder in
information pathways (7.1%) and transport (7.1%). A similar
pattern was observed for the proteins that were down-regulated in
kidney 129P3/J mice. The respective percentages were 50.0, 25.0,
16.7 and 8.3 (Table 1). From the differentially expressed proteins
in control groups, 10 were exclusively expressed in this compar-
ison whereas 2, 6, and 8 proteins were also present in either
10 ppmF or 50 ppmF or both F-treated groups, respectively
(Figure 1).
For the comparison between the A/J and 129P3/J mice treated
with 10 ppmF, 14 proteins were increased and 17 diminished in
kidney of 129P3/J. Among the increased proteins, 64.3% are
related with metabolism, while 35.7% are associated with cell
processes. Most of the decreased proteins are also related to
metabolism (41.1%), followed by information pathways (23.6%),
cell processes (17.6%), transport (11.8%) and structure (5.9%)
(Table 2). From the differentially expressed proteins in 10 ppmF
group, 15 were exclusively expressed in this comparison whereas
2, 6 and 8 proteins were also present in either control or 50 ppmF
or in both groups, respectively (Figure 1).
Regarding the comparison between the groups treated with
50 ppmF, 18 proteins were significantly up-regulated and
13 down-modulated in kidney of 129P3/J mice when compared
with A/J mice. Fourteen of eighteen enhanced proteins are
associated with metabolism (77.8%), followed by processes
(11.1%), information pathways (5.6%) and processes pathways
(5.6%). Among the down-modulated proteins, most are also
related to metabolism (46.2%), followed by cell processes (23.0%),
transport (15.4%), information pathways (7.7%) and structure
(7.7%) (Table 3). Among the differentially expressed proteins in
kidney of animals treated with 50 ppmF, 11 proteins are
exclusively expressed in this group while 6, 6 and 8 proteins are
also present in either control or 10 ppmF or both groups,
respectively (Figure 1).
Among the 8 proteins differentially expressed between the mice
strains, regardless of the treatment with F, catalase, medium-chain
specific acyl-CoA dehydrogenase and alpha-aminoadipic semi-
aldehyde dehydrogenase were up-regulated, while isovaleryl-CoA
dehydrogenase, ornithine aminotransferase, lactoylglutathione
lyase, meprin A subunit alpha and albumin were down-regulated
in the kidney of 129P3/J mice.
Identification of Unique Proteins
A/J and 129P3/J mice exhibited 11 and 3 exclusive proteins,
respectively. From these, 9 (64.3%) are related to metabolism,
followed by cell processes (4 or 28.6%) and information pathways
(1 or 7.1%). This profile was not altered upon exposure to F
(Table 4).
Discussion
In the present study, we identified proteins potentially involved
in renal F metabolism that are either exclusively or differentially
expressed in A/J and 129P3/J mice. This highlights the molecular
mechanisms underlying the differential metabolic handling of F by
these two strains of mice. Exclusive proteins expressed in A/J or
129P3/J mice exhibited the same profile, regardless exposure to F.
This suggests that the genetic background per se accounts for such
differences between these two strains of mice. We have focused on
identified proteins that may be associated with metabolic handling
of F and water and renal functions. Unique metabolic proteins in
kidney from A/J mice are involved in carbohydrate (probable D-
lactate dehydrogenase), carbon (transaldolase), aminoacid (iso-
butyryl-CoA dehydrogenase, hydroxymethylglutaryl-CoA syn-
Figure 1. Venn diagram showing distribution of total kidney
proteins identified with differences in expression from the 2D-
PAGE and LC-MS/MS-based proteome. The numbers indicate the
total protein identified from each comparison (control, 10 and 50 ppmF
A/J and 129P3/J) and the number of proteins commonly identified
between them.
doi:10.1371/journal.pone.0053261.g001
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thase (HMGCS2), cystathionine gamma-lyase (CSE), thiomorpho-
line-carboxylate dehydrogenase), and fatty acid [short-chain specific
acyl-CoA dehydrogenase (SCAD)] metabolism. CSE is an enzyme that
breaks down cystathione into cysteine and a-ketobutyrate and
catalyses elimination of L-homoserine, L-cystine and L-cysteine
producing ammonia and hydrogen sulfide (H2S) [19,20]. Consid-
ering that the urine is the main excretion route for ingested F [1],
the presence of CSE in A/J mice might contribute to increase the
urinary pH, which can help to explain the higher urinary F
excretion observed for this strain, when compared with the
129P3/J mice [10]. The pH-dependency found for urinary F
excretion is due to the fact that F can cross cell membranes in
general, including the walls of the renal tubules in the form of HF.
Thus, the higher the urinary pH, the higher the concentration of
F2 that remains in the tubule to be excreted in urine [12].
Recently, it was shown that the expression of HMGCS2 was
increased fourfold in diabetic kidneys, which leads to increased
renal ketogenesis and plays an important role in the pathogenesis
of diabetic nephropathy in type 2 diabetes [21]. In our data, the
presence of HMGCS2 in kidney of A/J mice might turn these
animals more prone to nephropathy, which could impair F
reabsorption in kidneys [10].
Besides presenting unique proteins involved in metabolism, A/J
mice also expresses exclusive proteins involved in cell processes
(phenazine biosynthesis-like domain containing protein 2 (PBLD),
biliverdin reductase A (BVR) and sorting nexin-5) and information
pathways [serum amyloid P-component (SAP)]. Among these,
SAP constitutes amyloid deposits characterized by the ordered
aggregation of normal globular proteins and peptides into
insoluble fibrils, which disrupt tissue architecture and are
associated with cell death [22]. The presence of SAP only in A/
J mice might increase the probability of kidney damage that could
account for their diminished capacity to reabsorb various solutes
including F, helping to explain the higher urinary F excretion seen
in this strain previously [10].
From those proteins found exclusively in kidneys of 129P3/J
mice, the peroxisomal acyl-coenzymeA oxidase 1 (AOX), a fatty
acid metabolic protein, is shown to be expressed in proximal
tubules and enhancement of its activity is associated with the
preservation of kidney function during ischemia [23]. Another
exclusive protein called arsenite-methyltransferase, presented only
in 129P3/J mice, is a detoxifying protein involved in the arsenic
biotransformation and elimination in proximal tubule epithelial
cells [24]. The presence of these proteins in 129P3/J but not in A/
J mice suggest that the former might have a higher capacity to
reduce renal damage caused by different hostile conditions, such as
exposure to F. Thus, the 129P3/J mice would be able to maintain
F reabsorption in kidneys even under exposure to high F doses
[10].
As mentioned above, F exposure did not alter the profile of
unique proteins in either strain of mice. However, among the
proteins differentially expressed in the comparisons between the
two strains, only 8 were present in the control, 10 and 50 ppmF
groups (catalase, medium-chain specific acyl-CoA dehydrogenase
Table 4. Expression of unique kidney proteins between A/J and 129P3/J mice.
Spot n6. Protein
aMw (kDa)/pI
Expt. bTheor.
cNumber of peptides/
Score dUniprot ID eBiological Process
Kidney A/J mice
563 Transaldolase 37.5/5.975 37.4/6.6 5/151 Q93092 Metabolism
564 Isobutyryl-CoA dehydrogenase,
mitochondrial
40.5/6.905 42.8/7.2 6/202 Q9D7B6 Metabolism
565 Short-chain specific acyl-CoA
dehydrogenase, mitochondrial
41/6.805 42.2/6.3 9/396 Q07417 Metabolism
567 Cystathionine gamma-lyase 43.5/7.99 43.6/7.6 5/163 Q8VCN5 Metabolism
568 Hydroxymethylglutaryl-CoA synthase,
cytoplasmic
56/5.7 57.6/5.65 2/62 Q8JZK9 Metabolism
586 Probable D-lactate dehydrogenase,
mitochondrial
37.5/8.23 19.1/6.2 2/84 Q7TNG8 Metabolism
562 Thiomorpholine-carboxylate
dehydrogenase
37.5/5.09 33.5/5.44 8/395 O54983 Metabolism
560 Phenazine biosynthesis-like domain-
containing protein 2
34/4.795 32/5.2 4/130 Q9CXN7 Process
561 Biliverdin reductase A 37.5/6.755 33.3/6.5 3/86 Q9CY64 Process
576 Sorting nexin-5 49.5/6.165 46.7/6.2 4/97 Q9D8U8 Process
558 Serum amyloid P-component 30/5.3 23.9/6.4 3/52 P12246 Information
Pathways
Kidney 129P3/J
mice
534/535 Peroxisomal acyl-coenzyme A oxidase 1 20.5/9.99 74.6/8.6 7/227 Q9R0H0 Metabolism
552 Nicotinate-nucleotide pyrophosphorylase
[carboxylating]
36/6.49 31.5/6.2 4/61 Q91X91 Metabolism
539 Arsenite methyltransferase 43/5.38 41.8/5.6 8/217 Q91WU5 Process
aExperimental molecular weight (kDa)/pI of protein spot in the gel (Mean of min. and max.) based on the coordinates of landmark proteins. bTheoretical molecular
weight (kDa)/pI of theoretical protein. cNumber of peptides identified and score. dIdentification is based on protein ID from IPI (international protein index) protein
database (http://www.uniprot.org/). eCategory of protein based on its primary biological function according to Rison (2000) [18].
doi:10.1371/journal.pone.0053261.t004
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and alpha-aminoadipic semialdehyde dehydrogenase (a-AASA),
isovaleryl-CoA dehydrogenase, ornithine aminotransferase, lac-
toylglutathione lyase, meprin A subunit alpha and albumin). Some
of these significantly altered proteins with potential roles to
contribute for the intrinsic differences in F and water handling by
A/J and 129P3/J mice are highlighted below. Meprin A, an
information pathways related protein, is an enzyme that hydro-
lyzes protein and peptide substrates including components of the
extracellular matrix [25]. It is highly expressed at the brush border
membrane of proximal tubule cells of the kidney. Inbred strains of
mice subjected to ischemia reperfusion that express low levels of
meprin A in kidney have markedly less kidney damage [26]. Our
data show that meprin A is consistently reduced in 129P3/J kidney
in all experimental conditions. This suggests that this protein could
act in concert with SAP to decrease renal damage caused by F in
129P3/J mice. Among the proteins related to cellular processes, it
is important to highlight a-AASA dehydrogenase and catalase. a-
AASA dehydrogenase metabolyzes irreversibly betaine aldehyde
to betaine, which is the most effective osmoprotectant accumulat-
ed by eukariotic organisms to cope with osmotic stress [27]. This
enzyme was increased in the 129P3/J kidney, regardless F
exposure. This can explain the lower volume of water consistently
ingested by the 129P3/J mice throughout the study, which led us
to adjust water F concentrations throughout the experiment in
order that both strains had the same amount of F intake from the
water [10]. The increased expression of the antioxidant enzyme
catalase might indicate a higher capacity of the 129P3/J mice to
deal with oxidative stress [28].
Two and 6 proteins with differential expression between the two
strains in the control group were also identified upon exposure to
10 and 50 ppmF, respectively. Low F level increased the
expression of serine/threonine-protein phosphatase PP1 and
ATP synthase subunit delta. High F level kidney up-expressed
aconitate hydratase, ATP synthase subunit beta, hydroxyacid
oxidase 2, homogentisate 1,2-dioxygenase and beta-lactamase-like
protein 2 and down-expressed phosphotriesterase-related protein.
Besides, 6 proteins presented altered expression only in F-treated
groups. Aminoacylase-1 and aspartoacylase-2 were increased,
whereas L-lactate dehydrogenase B chain, nucleoside diphos-
phate-linked moiety X motif 19, Na(+)/H(+) exchange regulatory
cofactor NHE-RF3 (PDZK1) and actin-related protein 3 were
diminished in 129P3/J kidney. These proteins may act as
molecular targets for the differential F metabolism between these
strains induced by the treatment. Protein phosphatase 1 (PP1) is a
serine/threonine protein phosphatase involved in diverse cellular
processes, such as transcription, replication, pre-mRNA splicing,
protein synthesis, carbohydrate metabolism, neuronal signaling,
cell survival, and cell cycle progression [29,30]. Phosphatases
typically function antagonistically with kinases to achieve fine
control over the phosphorylation state of proteins. Phosphatases
are widely expressed enzymes that mediate the functional
regulation of many proteins, including some renal channels and
transporters such as the inwardly rectifying K+ channel, Na+-K+-
Cl2 cotransporter (NKCC1), CFTR, epithelial Na+ channel
(ENaC), aquaporin-2 (AQP2) and Na+/H+ exchanger 3 (NHE3)
[30,31,32,33,34,35,36]. In general, these ions and water channels
are responsible to maintain the urine normal volume and acid-
base status under varying physiological conditions and are under
direct or indirect phosphorylation state control [37,38]. It was
shown that the prevention of phosphorylation of specific sites in
AQP2 increases localization of AQP2 vesicles to the apical plasma
membrane leading to water reabsorption and urine concentration
[38]. Thus, we could speculate that the fact that 129P3/J mice
excrete less urine could be possibly explained by the PP1-mediated
enhancement of AQP2 vesicles trafficking, which should be
confirmed in future studies.
PDZK1 is a scaffold protein that connects plasma membrane
proteins and regulatory components, regulating their surface
expression in epithelial cells apical domains. Within the kidney,
PDZK1 is localized exclusively in the brush border of the proximal
tubule and interacts with several renal proteins including NHE3, a
Na-H exchanger, and CFEX, a Cl-anion exchanger [39]. These
exchanger transporters play principal roles in the reabsorption of
Na+ and Cl2 in the proximal tubule of the mammalian kidney.
Besides regulating reabsorption of filtered solutes, PDZK1 also
plays a direct and essential role in maintaining normal brush
border expression and function of CFEX in the proximal tubule
in vivo [39]. The diminished expression of PDZK1 in kidney of
129P3/J mice may indicate an undisclosed impaired ability of ion
reabsorption by this strain, which is consistent with the lower
volume of urine excreted by these mice.
We conclude that the renal proteome indicates several specific
target proteins, both strain and F-induced, which possibly regulate
the water and F metabolism in kidney of mice with distinct
susceptibilities to F. In addition, although we did not focus in the
correlation between target kidney proteins and DF, we found that
some of those changed proteins are also codified by chromosomes
2 (13 proteins: sarcosine dehydrogenase, catalase, sorbitol dehy-
drogenase, isovaleryl-CoA dehydrogenase, creatine kinase U-type,
phosphotriesterase-related protein, proteasome subunit beta type-
7, adenoxylhomocysteinase, protein disulfide-isomerase A3, argi-
ninosuccinate synthase, glycine amidinotransferase, biliverdin
reductase A and sorting nexin-5) and 11 (3 proteins: peroxisomal
acyl-coenzyme A oxidase 1, ATP synthase subunit d and Rho
GDP-dissociation inhibitor 1), previously characterized to deter-
mine susceptibility and resistance to DF in A/J and 129P3/J mice,
respectively [40,41]. This correlation may provide a database for
future hypothesis-driven researches.
Supporting Information
Figure S1 2D gel analysis of renal proteome. Represen-
tative 2D maps of control kidneys. Selected spots in green
represent those with differential expression in the comparison
between control A/J (A) vs control 129P3/J mice (B). In Figure B,
spot identification numbers in boundaries or not represents
increases or decreases in protein expression when compared to
A/J, respectively (Figure A). Dashed lines represent unique spots in
the AJ group (A) and 129P3/J group (B), regardless exposure to F.
(TIF)
Figure S2 2D gel analysis of renal proteome. Represen-
tative 2D maps of 10 ppmF treated-groups. Selected spots in green
represent those with differential expression in the comparison
between 10 ppmF treated- A/J (A) vs 10 ppmF treated- 129P3/J
mice (B). In Figure B, spot identification numbers in boundaries or
not represents increases or decreases in protein expression when
compared to A/J, respectively (Figure A).
(TIF)
Figure S3 2D gel analysis of renal proteome. Represen-
tative 2D maps of 50 ppmF treated-groups. Selected spots in green
represent those with differential expression in the comparison
between 50 ppmF treated- A/J (A) vs 50 ppmF treated- 129P3/J
mice (B). In Figure B, spot identification numbers in boundaries or
not represents increases or decreases in protein expression when
compared to A/J, respectively (Figure A).
(TIF)
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Figure S4 2D gel variability analysis. Scatter plot of binary
comparisons among the ratios of relative spots volumes detected in
the representative gel (replicate 1) and the respective replicates
(replicates 2 and 3). (A) Control A/J mice. (B) 10 ppmF treated-A/
J mice. (C) 50 ppmF treated-A/J. (D) Control 129P3/J mice. (E)
10 ppmF treated-129P3/J mice. (F) 50 ppmF treated-129P3/J.
(TIF)
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